Table 2 Summary of radiotherapy outcomes
From: Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer
Patient | Target | Treatment date | Progression prior to radiotherapy | Outcome | Fractionated dose | Total dose |
|---|---|---|---|---|---|---|
1. | Th1 Th10 | 2012, 2018 | No No data | SD No data | 10 Gy 6 | 10 18 |
2. | Th7 L4 | 2016 2016 | No No data | SD | 10 10 | 30 30 |
3. | Th8 | 2008 | No | SD | 10 | 10 |
4. | Liver | 2019 | YES | SD | 12 | 12 |
5. | L4 Th2 | 2012 2011 | No No data | PR PR | 8 8 | 16 16 |
6. | Skull Liver | 2012 2012 | YES YES | SD No data | 10 8 | 10 8 |
7. | LN | 2018 | YES | SD | 8 | 24 |
8. | Th6 L1 | 2013 2013 | YES YES | SD SD | 7 10 | 21 20 |
9. | Recurrence | 2006 | No | SD | 8 | 8 |
10. | Primary thyroid tumor | 2017 | YES | SD | 12 | 36 |
11. | LN | 2016 | YES | SD | 5 | 45 |